- Home
- THR vs AVBP Comparison
THR vs AVBP Comparison
Compare THR & AVBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THR
- AVBP
- Stock Information
- Founded
- THR 1954
- AVBP 2021
- Country
- THR United States
- AVBP United States
- Employees
- THR N/A
- AVBP N/A
- Industry
- THR Industrial Machinery/Components
- AVBP
- Sector
- THR Energy
- AVBP
- Exchange
- THR Nasdaq
- AVBP NYSE
- Market Cap
- THR 960.7M
- AVBP 948.5M
- IPO Year
- THR 2011
- AVBP 2024
- Fundamental
- Price
- THR $28.69
- AVBP $26.09
- Analyst Decision
- THR Strong Buy
- AVBP Strong Buy
- Analyst Count
- THR 1
- AVBP 5
- Target Price
- THR $38.00
- AVBP $36.80
- AVG Volume (30 Days)
- THR 209.4K
- AVBP 169.6K
- Earning Date
- THR 01-30-2025
- AVBP 02-02-2025
- Dividend Yield
- THR N/A
- AVBP N/A
- EPS Growth
- THR 4.78
- AVBP N/A
- EPS
- THR 1.29
- AVBP N/A
- Revenue
- THR $493,855,000.00
- AVBP N/A
- Revenue This Year
- THR $2.25
- AVBP N/A
- Revenue Next Year
- THR $8.83
- AVBP N/A
- P/E Ratio
- THR $22.26
- AVBP N/A
- Revenue Growth
- THR 3.94
- AVBP N/A
- 52 Week Low
- THR $23.76
- AVBP $14.35
- 52 Week High
- THR $35.93
- AVBP $36.37
- Technical
- Relative Strength Index (RSI)
- THR 32.13
- AVBP 40.46
- Support Level
- THR $30.95
- AVBP $25.01
- Resistance Level
- THR $33.25
- AVBP $27.66
- Average True Range (ATR)
- THR 1.03
- AVBP 1.39
- MACD
- THR -0.49
- AVBP -0.22
- Stochastic Oscillator
- THR 4.20
- AVBP 20.93
About THR Thermon Group Holdings Inc.
Thermon Group Holdings Inc is a United States-based company that provides engineered thermal solutions for process industries. The company's product portfolio comprises electric heat tracing cables, steam tracing components, tubing bundles, and instrument and control products, as well as complementary product lines. It also provides turnkey services and design and engineering services. The company's customers include large engineering, procurement, and construction companies; oil and gas companies; commercial subcontractors; electrical component distributors; and others. The company has a presence, with the United States, Canada, and Europe being its top three markets and contributing the majority of its sales.
About AVBP ARRIVENT BIOPHARMA INC
ArriVent BioPharma Inc is a clinical stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize team's deep drug development experience to maximize the potential of lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.